Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT03267511Phase 2Completed
Phase 2, randomised, single-blind trial in extrinsic dental stain and dental plaque (4 arms), sponsored by GSK. Primary endpoint: MacPherson Modification of the Lobene Stain Index at 8 weeks. Started Sep 2017; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT03267511.